Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Therapeutic plasma exchange in neuromyelitis optica: A case series.
Autologous Haematopoietic Stem Cell Transplantation with Reduced Intensity Conditioning in Multiple Sclerosis.
Acute combined central and peripheral demyelination showing anti-aquaporin 4 antibody positivity.
The hepatocyte growth factor (HGF)-MET receptor tyrosine kinase signaling pathway: Diverse roles in modulating immune cell functions.
mTOR kinase, a key player in the regulation of glial functions: Relevance for the therapy of multiple sclerosis.
Dalfampridine in hereditary spastic paraplegia: a prospective, open study.
Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor).
Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells.
Alemtuzumab (LEMTRADA) and multiple sclerosis. Biased evaluation, evidence of serious risks.
Choosing the best treatment for multiple sclerosis: comparative effectiveness, safety, and other factors involved in disease-modifying therapy choice.
Antiinflammatory activity of glucomoringin isothiocyanate in a mouse model of experimental autoimmune encephalomyelitis.
Clinical trials to clinical use: using vision as a model for multiple sclerosis and beyond.
Anorectal dysfunction in multiple sclerosis: a systematic review.
Histone deacetylase activity is required for human oligodendrocyte progenitor differentiation.
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis.
Exercise, brain, and cognition across the life span.
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers.
ISENTRESS® prescribing information
Prenatal vitamin d deficiency induces an early and more severe experimental autoimmune encephalomyelitis in the second generation.
Structural and Metabolic Features of Two Different Variants of Multiple Sclerosis: A PET/MRI Study.
B-cell targeted therapeutics in clinical development.
Cortical reorganization in multiple sclerosis after intrathecal baclofen therapy.
A review of current and emerging therapeutic strategies in multiple sclerosis.
Hypoxia Inducible Factor-1α in Astrocytes and/or Myeloid Cells Is Not Required for the Development of Autoimmune Demyelinating Disease(,.)
Aquatic training in MS: neurotherapeutic impact upon quality of life.

Pages